Arcellx (ACLX) EV to Revenue (2023 - 2026)
Arcellx (ACLX) EV to Revenue (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EV to Revenue |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
39.46 Mn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
3,065.60 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
42.37 |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
8.62 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
17,434.90 |
| 10 |
Arcellx |
6.48 Bn |
6.48 Bn |
- |
290.76 |
| Date | Value |
|---|
| Apr 27, 2026 |
290.76 |
| Apr 24, 2026 |
290.66 |
| Apr 23, 2026 |
290.71 |
| Apr 22, 2026 |
290.59 |
| Apr 21, 2026 |
290.54 |
| Apr 20, 2026 |
290.59 |
| Apr 17, 2026 |
290.71 |
| Apr 16, 2026 |
290.84 |
| Apr 15, 2026 |
290.59 |
| Apr 14, 2026 |
290.31 |
| Apr 13, 2026 |
290.26 |
| Apr 10, 2026 |
290.16 |
| Apr 9, 2026 |
290.08 |
| Apr 8, 2026 |
290.06 |
| Apr 7, 2026 |
290.08 |
| Apr 6, 2026 |
289.88 |
| Apr 2, 2026 |
290.01 |
| Apr 1, 2026 |
289.95 |
| Mar 31, 2026 |
290.13 |
| Mar 30, 2026 |
290.01 |
